Compare Acadia Healthcare Company Inc (ACHC) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Acadia Healthcare Company Inc vs PepsiCo, Inc. — how do they compare? Acadia Healthcare Company Inc trades at $30.77 (market cap $2.94B), while PepsiCo, Inc. trades at $143.62 (market cap $198.15B). The key difference: PepsiCo, Inc. is far larger — about 67.4× Acadia Healthcare Company Inc's market cap, and PepsiCo, Inc. pays a 4.08% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | PEP | |
|---|---|---|
Market Cap | $2.94B | $198.15B |
Sector | Health | Consumer Staples |
52-Week High | $31.92 | $170.44 |
52-Week Low | $11.68 | $133.81 |
Enterprise Value | $5.45B | $240.05B |
Dividend Yield | — | 4.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.
The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.
PepsiCo (PEP) trades at $143.51, showing minimal daily movement with a 0.15% gain. The stock maintains a bullish technical signal despite bearish moving averages, supported by strong fundamentals including consistent earnings beats and robust profitability metrics. Recent news highlights price adjustments in snack products and institutional accumulation, while the company prepares for Q1 2026 earnings with expectations of in-line results and ongoing North American recovery focus.
PepsiCo presents a stable investment case with strong cash flow generation and dividend reliability, though margin pressures and competitive pricing dynamics pose near-term risks. Analyst consensus leans bullish with a $161.73 price target, suggesting 13% upside potential from current levels, supported by institutional confidence and strategic business optimization initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Acadia Healthcare Company Inc
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
